PPM1H is a p27 phosphatase implicated in trastuzumab resistance
about
Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumabp27(Kip1) controls cytokinesis via the regulation of citron kinase activation.Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H.12q14 Microdeletions: Additional Case Series with Confirmation of a Macrocephaly RegionResistance to HER2-targeted therapies: a potential role for FOXM1.Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance.Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells.Improving treatment of HER2-positive cancers: opportunities and challenges.Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic.The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness.Regulation of p27Kip1 phosphorylation and G1 cell cycle progression by protein phosphatase PPM1G.Subtype identification from heterogeneous TCGA datasets on a genomic scale by multi-view clustering with enhanced consensus.Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer.The impact of phosphatases on proliferative and survival signaling in cancer.Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer
P2860
Q26764879-12FFE916-F465-4DC1-BEA0-2D0239F26396Q30505731-3404810A-AF7E-4AE0-8B48-3941B5E3BDBDQ33701824-2684BA63-22CE-4976-AC8A-8F037E7269F5Q34489183-A15F1EEC-B7A1-4554-889F-1E8A5396B9E8Q34955355-6C4E2995-BC03-4076-89E7-C21E443722CCQ35624814-ABF9B601-9450-4CED-A950-B765162D6998Q37565022-1610EC10-38B5-4AD7-8BCE-0560798FD3CFQ37998453-D0EE8EF5-550E-4B0A-9C01-ED63F2F8505FQ38214802-EC88C7C8-2049-4B3C-8A4E-36FBACF8E55FQ38890318-094D2BBC-06A1-49AF-B8A9-65378C7DA84CQ41632273-B50BA513-57C8-4893-B1F7-B2A4FF69AAFEQ47565449-BE0E9AB6-7074-462B-955C-0F7C87F260DFQ49544395-81D1C9E8-6587-41C2-BE4B-79D20E4422CEQ54112403-5D4E3786-4D66-4B45-8D3C-D2D28C70AD16Q57494120-D3C49AB3-F0F3-4B6F-9C6D-D83F2A57AC11
P2860
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@ast
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@en
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@en-gb
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@nl
type
label
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@ast
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@en
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@en-gb
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@nl
prefLabel
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@ast
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@en
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@en-gb
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@nl
P2093
P1433
P1476
PPM1H is a p27 phosphatase implicated in trastuzumab resistance
@en
P2093
Ajay Pandita
David P Davis
Don Dowbenko
Howard M Stern
Jeremy Stinson
Kanan Pujara
Karen A Gelmon
Klaus P Hoeflich
P304
P356
10.1158/2159-8290.CD-11-0062
P407
P577
2011-09-01T00:00:00Z